Medpace Holdings (MEDP) news
Recent news
Medpace Holdings, Inc.: UBS raises to neutral from sell
UBS has upgraded its rating for Medpace Holdings, Inc. (MEDP) to "neutral" from "sell," marking a shift in the firm's outlook for the clinical research organization. The decision follows recent analyst activity and broader market assessments of the healthcare and biotechnology sectors. While the…
AInvest Wire · Sep 30, 2026Medpace Holdings, Inc. to report third quarter 2026 financial results on October 21, 2026
Medpace Holdings, Inc. has announced that it will release its third quarter 2026 financial results on Monday, October 21, 2026. The company typically provides quarterly updates to keep investors informed about its financial performance and operational progress. The upcoming report will include key…
AInvest Wire · Sep 22, 2026Medical Park 2Q net income 1.37B liras, -0.7% y/y
Medical Park reported a net income of 1.37 billion liras for the second quarter of 2026, representing a 0.7% year-over-year decline . This performance contrasts with the broader healthcare sector, where companies like Medpace and Centene have shown significant growth in revenue and profitability.…
AInvest Wire · Aug 6, 2026BMO raises target price to $600 from $400 for Medpace Holdings Inc
AInvest Wire · Jul 24, 2026Medpace Holdings Inc: TD Cowen raises target price to $492 from $419
AInvest Wire · Jul 24, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.